News for Aptevo Therapeutics Inc. (APVO)

Marvin White, President and CEO, Talks Clinical Progress, Innovation and Long-Term Growth ORLANDO, FL / ACCESS Newswire / February 15, 2025 / RedChip Companies

100% of Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment Co

Also giving an in-session talk titled

Here is how Aptevo Therapeutics Inc. (APVO) and Accuray (ARAY) have performed compared to their sector so far this year.

Biohaven Ltd. (BHVN) experienced a significant stock drop of 5.18%, trading at $38.08. The trading volume reached 534,139 shares, with a turnover rate of 0.53%

SEATTLE, WASHINGTON / ACCESSWIRE / December 12, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology compan

Two of three patients achieved both complete remission and MRD-negative statusHigh response rates observed in earlier studies continue in ongoing mipletamig tri

Powered by Aptevo's proprietary ADAPTIR-FLEX®platform, antibody innovation targeting difficult-to-treat cancers SEATTLE, WA / ACCESSWIRE / December 4, 2024 / A

SEATTLE, WA / ACCESSWIRE / November 29, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a revers

Aptevo's Peter Pavlik, PhD, to chair a session on

U.S. stocks traded lower this morning, with the Dow Jones index dipping more than 250 points on Wednesday. Following the market opening Wednesday, the Dow trad...

Shares of Stride, Inc. LRN rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and issued...

Regeneron Pharmaceuticals (REGN) experienced a significant stock decline, dropping by 5.01%. The stock is currently priced at $920.00 per share, with a trading

Therapeutics company Adagene (ADAG) experienced significant stock movement with a sharp decline of 7.04%. The stock is currently priced at $2.51 per share, with

Shares of Intel Corporation INTC rose sharply in today's pre-market trading after the company announced a strategic collaboration with AWS to help advance US-ba...

Maryland-based life sciences business Emergent BioSolutions Inc. (EBS) is up over 54% in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Maryland-based life sciences business Emergent BioSolutions Inc. (EBS) is up over 54% in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94. The S&P 500 also rose, gaining, 0.17% to 5,169.21.